Search

Sana Biotechnology Inc

Отворен

СекторЗдравеопазване

2.93 -7.28

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

3.05

Максимум

3.34

Ключови измерители

By Trading Economics

Приходи

-16M

-64M

EPS

-0.13

Служители

142

EBITDA

-17M

-61M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+140.24% upside

Дивиденти

By Acuity

Следващи печалби

4.11.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

43M

928M

Предишно отваряне

10.21

Предишно затваряне

2.93

Настроения в новините

By Acuity

25%

75%

35 / 339 Класиране в Healthcare

Sana Biotechnology Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

22.09.2026 г., 23:46 ч. UTC

Sana Biotechnology Inc is declining in after-market trading, driven by broader economic concerns following a drop in the Richmond Fed Manufacturing Index.

21.09.2026 г., 19:35 ч. UTC

Sana Biotechnology Inc shares fell modestly, fluctuating throughout the day and remaining significantly below its 20-day moving average.

17.09.2026 г., 20:07 ч. UTC

Correlated Moves

Sana Biotechnology Inc is advancing as the ARK Genomic Revolution ETF gains, driven by strong performances from holdings like Tempus AI and Twist Bioscience.

16.09.2026 г., 23:07 ч. UTC

Correlated Moves

Sana Biotechnology Inc is advancing in after-market trading, reflecting notable gains since Wednesday's close, possibly in sympathy with Recursion Pharmaceuticals Inc.

15.09.2026 г., 23:06 ч. UTC

Sana Biotechnology Inc. shares are lower in after-market trading, reflecting broader market trends and remaining below their 20-day moving average.

14.09.2026 г., 20:03 ч. UTC

Correlated Moves

Sana Biotechnology Inc. is trading higher today, benefiting from strong market activity alongside Recursion Pharmaceuticals Inc. despite remaining below its 20-day moving average.

11.09.2026 г., 23:46 ч. UTC

Sana Biotechnology Inc. shares are higher in after-market hours, despite no specific news identified. Broader market context includes recent U.S. inflation data.

10.09.2026 г., 20:07 ч. UTC

News
Correlated Moves

Sana Biotechnology Inc shares are lower amid a broader biotechnology sector decline, influenced by rising Treasury yields and inflation concerns affecting market sentiment.

9.09.2026 г., 23:01 ч. UTC

Sana Biotechnology Inc. shares are higher in after-market hours, recovering from earlier declines amid unclear drivers for the price movement.

8.09.2026 г., 20:03 ч. UTC

News

Sana Biotechnology shares are declining despite a report on diabetes treatment advancements and a $25 million investment from Mayo Clinic.

4.09.2026 г., 20:07 ч. UTC

Sana Biotechnology Inc shares are lower amid broader market pressures following a strong jobs report, with no specific company news identified.

2.09.2026 г., 20:08 ч. UTC

Social Media
News

Sana Biotechnology Inc is advancing today amid gains in the Biotechnology sector and upcoming investor conferences focused on engineered cell therapies.

31.08.2026 г., 20:07 ч. UTC

Sana Biotechnology Inc. shares decline today, continuing a trend since Friday's close, amid broader market pressures from rising interest rate expectations.

28.08.2026 г., 23:56 ч. UTC

Sana Biotechnology Inc. shares advanced modestly higher in after-market trading, remaining near the upper end of their one-month range.

27.08.2026 г., 23:02 ч. UTC

Sana Biotechnology shares declined in after-market trading, reflecting a notable drop since Thursday's close, despite earlier gains earlier in the session.

26.08.2026 г., 19:46 ч. UTC

Sana Biotechnology Inc shares are higher today, trading near the upper end of their one-month range and above the 20-day moving average.

25.08.2026 г., 23:16 ч. UTC

Sana Biotechnology Inc shares are lower in after-market hours. Market sentiment was affected by a sharp decline in crude oil prices.

24.08.2026 г., 19:36 ч. UTC

Correlated Moves

Sana Biotechnology Inc's shares are lower today, reflecting broader declines in the biotech sector, including a drop in the ARK Genomic Revolution ETF.

21.08.2026 г., 23:36 ч. UTC

Sana Biotechnology Inc. shares moved lower in after-market trading, despite resilience in major stocks like Tesla and UnitedHealth. The price remains above its 20-day moving average.

20.08.2026 г., 23:01 ч. UTC

Sana Biotechnology Inc. shares are higher in after-hours trading, driven by gains in the Biotechnology sub-sector and remaining above its 20-day moving average.

19.08.2026 г., 23:06 ч. UTC

Sana Biotechnology Inc shares are lower in after-market hours, following a notable decline from earlier highs. No specific news was identified to explain the move.

18.08.2026 г., 19:46 ч. UTC

Sana Biotechnology Inc. shares are lower today, reflecting a decline since Monday amid rising Treasury yields and ongoing inflation concerns.

17.08.2026 г., 23:46 ч. UTC

Sana Biotechnology Inc shares are slightly higher in after-market hours. No specific news was identified to explain the movement.

14.08.2026 г., 20:06 ч. UTC

News

Sana Biotechnology shares declined amid mixed analyst ratings and broader market challenges, with BofA lowering its price target to $6.00 from $7.00.

13.08.2026 г., 19:36 ч. UTC

Sana Biotechnology Inc shares are lower today, continuing a decline since Wednesday. The price remains above its 20-day moving average.

12.08.2026 г., 23:46 ч. UTC

Sana Biotechnology Inc shares are lower in after-market hours, with no specific news identified to explain the price movement.

11.08.2026 г., 19:31 ч. UTC

News

Sana Biotechnology shares are higher following Q2 results showing an adjusted EPS of -$0.13, exceeding estimates, and a $25 million investment from Mayo Clinic.

10.08.2026 г., 23:01 ч. UTC

News

Sana Biotechnology Inc shares are lower in after-market hours following a second-quarter loss of $63.6 million, despite an adjusted EPS that exceeded expectations.

7.08.2026 г., 19:56 ч. UTC

Sana Biotechnology Inc. shares are higher, supported by broader market dynamics following a disappointing jobs report easing interest rate concerns.

5.08.2026 г., 19:56 ч. UTC

Sana Biotechnology Inc. is trading higher during Wednesday's session, having peaked earlier before pulling back slightly while remaining above its 20-day moving average.

Сравнение с други в отрасъла

Ценова промяна

Sana Biotechnology Inc Прогноза

Ценова цел

By TipRanks

140.24% нагоре

12-месечна прогноза

Среден 8 USD  140.24%

Висок 12 USD

Нисък 6 USD

Според 5 анализатори от Wall Street, предложили 12-месечна ценова цел за Sana Biotechnology Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

5 ratings

5

Купи

0

Задържане

0

Продай

Настроение

By Acuity

35 / 339 Класиране в Здравеопазване

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Среден

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Sana Biotechnology Inc

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, B-cell-mediated autoimmune, and others. The company's product candidates include SC291 that is used as allogeneic cell therapies for hematologic malignancies; ARDENT for a potential treatment for non-Hodgkin's lymphoma, and chronic lymphoblastic leukemia; GLEAM, to treat multiple autoimmune disorders that involve production of autoimmune antibodies, including lupus nephritis, extrarenal lupus, antineutrophil cytoplasmic antibody -associated vasculitis, and others. It is developing SC262 to treat patients with relapsed and/or refractory B-cell malignancies; SC255 for multiple myeloma treatment; SC379, a therapy for patients with certain central nervous system disorders healthy allogeneic glial progenitor cells; SC451, a product candidate to treat diabetes, with an initial focus on type 1 diabetes mellitus; and UP421 that reduces long-term exogenous insulin dependence. The company has an option and license agreement with Beam Therapeutics Inc. for use of Beam's proprietary CRISPR Cas12b nuclease editing technology to research, develop, and commercialize engineered cell therapy products; and a license agreement with Harvard College to access certain intellectual property for the development of hypoimmune-modified cells. The company was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. Sana Biotechnology, Inc. was incorporated in 2018 and is headquartered in Seattle, Washington.